We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Salty Commune is a dedicated co working space for the creative community, inspired by rock and roll.  They have secured an iconic building in Shoreditch which is due to launch in April and are now looking for investment to acquire more properties.
days to go: Expired investment: £219,692
rais is a virtual customer data analyst designed to stop socially unintelligent marketing and save the customers heaps of time in the process. The clever software platform of rais imports customer data from first-party sources to automatically deduplicate records. The monthly recurring revenue of rais is above £20K, and it has worked with more than 50 brands. Its software is trusted by many businesses like Original Cottages, Heartier, and Warner Edwards. Analyses engines kick in enriched customer meta-data that syncs with marketing channels to stop, start, or adjust marketing messages automatically based on individual customer circumstances. rais' vision is to build a virtual data-analyst for SMEs who do not have the time and ability to really leverage their customer data assets.
days to go: Expired investment: £150,000
A travel club and booking service offering a wide range of villas, boutique hotels and getaway experiences. Mr & Mrs Smith has over 1.5m members who have collectively made bookings valued at more than £60m in the last 12 months. The company generates income from commissions, which has resulted in revenues of £13m in 12 months up to 30 June 2018. They are now seeking to expand their travel collection and acquire US membership.
days to go: Expired investment: £5,926,375
iBan Wallet has created an app which allows users to be in control of their finances, connecting them to the people involved in any transaction. They will create a space for investors and also for borrowers, allowing the borrowers to be in control of the amount of interest they pay. 
days to go: Expired investment: £111,648
Growthdeck is seeking up to £1 million in funding to capitalize on a positive economic environment and a promising pipeline of opportunities. Despite challenging economic conditions in recent years, the company has outperformed the industry by achieving year-on-year growth in equity fundraising and improving deal flow and quality. With enhanced efficiency and reduced costs, Growthdeck is well-positioned to resume its rapid growth trajectory. Investor interest has rebounded, and the company's increased understanding of investor preferences allows them to identify more suitable deals. Having obtained FCA authorization as a Fund Manager, Growthdeck plans to launch Funds in 2023. The company's objective is to build a business worth over £50 million by 2027, catering to high and ultra-high net worth investors by arranging investments in private companies, backed by a loyal member base. 
days to go: Expired investment: Withheld
VINEX is a digital Business-To-business (B2B) trading platform that connects buyers and sellers to source, sample, negotiate and execute contracts related to wine. The company has traded more than 115 million bottles of wine across 26 countries since 2016. It has also witnessed 3,200 monthly visitors on its platform with an average of 80 million litres of wine traded each month, from 16 countries. The company recently launched VINPay, an industry-first financial technology service customised for the wine industry, providing wineries with guaranteed payment and increased access to capital liquidity. VINEX argues that VINPay attracts wineries with earlier access to cash and empowers buyers to buy better, with up to 150 days to pay. The company aims to become a contender in the wholesale wine market that is set to exceed US$381 billion in 2021. VINEX will use the investment to help wineries invest and flourish.
days to go: Expired investment: £114,218
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph